3,4-methylenedioxymethamphetamine (MDMA): An important cause of acute hepatitis

Medical Science Monitor

Volumn 12, Issue 11, 2006, Pages

  Brnčić, Nada ^a   Kraus, Ivan ^a   Višković, Ivica ^a   Mijandrušić Sinčić, Brankica ^a   Vlahović Palečevski, Vera ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

Hepatitis; Hepatotoxicity; HLA; Liver; MDMA ecstasy; Pathogenesis

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ACUTE HEPATITIS; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONVALESCENCE; DISEASE COURSE; HISTOPATHOLOGY; HLA TYPING; HUMAN; HUMAN TISSUE; INTRAHEPATIC CHOLESTASIS; JAUNDICE; LABORATORY TEST; LIVER INJURY; MALE;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; HALLUCINOGENS; HEPATITIS, TOXIC; HLA ANTIGENS; HUMANS; LIVER; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PHENOTYPE; PROGNOSIS; TIME FACTORS;

EID: 33750943697     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Henry JA, Jeffreys KJ, Dawling S: Toxicity and deaths from 3,4- Methyl enedioxymethamphetamine ("ecstasy"). Lancet, 1992; 340: 384-87
2. Andreu V, Mas A, Bruguera M et al: Ecstasy: a common cause of severe acute hepatotoxicity. J Hepatol, 1998; 29: 394-97
3. Garbino J, Henry JA, Mentha G, Romand JA: Ecstasy ingestion and fulminant hepatic failure: Liver transplantation to be considered as a last therapeutic option. Vet Human Toxicol, 2001; 43: 99-102
4. Dykhuizen RS, Brunt PW, Atkinson P et al: Ecstasy-induced hepatitis mimicking viral hepatititis. Gut, 1995; 36: 939-41
5. Ellis AJ, Wendow JA, Portman B, Williams R: Acute liver damage and ecstasy ingestion. Gut, 1996; 38: 454-58
6. Khakoo SI, Coles CJ, Armstrong JS, Barry RE: Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymethamphetamine (MDMA) usage. J Clin Gastroenterol, 1995; 20: 244-47
7. Carvalho M, Carvalho F, Bastos ML: Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-Methylenedioxymethamphetamin e (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes. Arch Toxicol, 2001; 74: 789-93
8. Fidler H, Dhillon A, Gertner D, Burroughs A: Chronic ecstasy 3,4-methylenededioxymethamphetamine abuse a recurrent and unpredictable cause of severe acute hepatits. J Hepatolog, 1996; 25: 563-66
9. Lautt WW: Intrinsic regulation of hepatic blood flow. Can J Physiol Pharmacol, 1996; 74: 223-33
10. Jones AL, Simpson KJ: Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment Pharmacol Ther, 1999; 13: 129-33
11. Eade OE, Grice D, Krawitt EL et al: HLA A and B locus antigens in patients with unexplained hepatitis following halothane anesthesia. Tissue Antigens, 1981; 17: 428-32
12. Stricker BHCh, Block R, Claas FHJ et al: Hepatic injury associated with the use of nitrofurans: a clinico-pathological study of 52 reported cases. Hepatology, 1988; 8: 599-606
13. Pariente A, Hamoud A, Goldfain D et al: Hepatites a la clommetacine (Duperan). Etude retrospective de 30 cas. Un modele d hepatite immunoallergique. Gastroenterol Clin Biol, 1989; 13: 769-74
14. Berson A, Freneaux E, Lyrrey D et al: Possible role of HLA in hepatotoxicity. J Hepatol, 1994; 20: 336-42